SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Ariba Technologies (Nasdaq-ARBA) -- Ignore unavailable to you. Want to Upgrade?


To: Suzanne Newsome who wrote (1809)3/21/2001 1:34:16 PM
From: Suzanne Newsome  Respond to of 2110
 
Milberg Weiss Announces Class Action Suit Against Ariba, Inc.
NEW YORK , NY, Mar 21, 2001 (INTERNET WIRE via COMTEX) -- The law firm of Milberg Weiss Bershad Hynes & Lerach LLP announces that a class action lawsuit was filed on March 20, 2001, on behalf of purchasers of the securities of Ariba, Inc. ("Ariba or the "Company") (NASDAQ: ARBA chart, msgs) between June 23, 1999 and December 23, 1999 inclusive. A copy of the complaint filed in this action is available from the Court, or can be viewed on Milberg Weiss' website at: www.milberg.com/ariba/

The action, numbered 01 Civ. 2359, is pending in the United States District Court for the Southern District of New York, located at 500 Pearl Street, New York, NY 10007, against defendants Ariba, Morgan Stanley & Co. Incorporated ("Morgan Stanley"); Keith J. Krach and Edward P. Kinsey. The Honorable John S. Martin Jr. is the Judge presiding over the case.

The complaint alleges violations of Sections 11, 12(a)(2) and 15 of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. On June 23, 1999, Ariba commenced an initial public offering of 5 million of its shares of common stock at an offering price of $23 per share (the "Ariba IPO"). In connection therewith, Ariba filed a registration statement, which incorporated a prospectus (the "Prospectus"), with the SEC. The complaint further alleges that the Prospectus was materially false and misleading because it failed to disclose, among other things, that: (i) Morgan Stanley had solicited and received excessive and undisclosed commissions from certain investors in exchange for which Morgan Stanley allocated to those investors material portions of the restricted number of Ariba shares issued in connection with the Ariba IPO; and (ii) Morgan Stanley had entered into agreements with customers whereby Morgan Stanley agreed to allocate Ariba shares to those customers in the Ariba IPO in exchange for which the customers agreed to purchase additional Ariba shares in the aftermarket at pre-determined prices. As alleged in the complaint, the SEC is investigating underwriting practices in connection with several other initial public offerings.

If you bought the securities of Ariba between June 23, 1999 and December 23, 1999 you may, no later than May 21, 2001, request that the Court appoint you as lead plaintiff in this action. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. In order to be appointed lead plaintiff, the Court must determine that the class member's claim is typical of the claims of other class members, and that the class member will adequately represent the class. Under certain circumstances, one or more class members may together serve as "lead plaintiff." Your ability to share in any recovery is not, however, affected by the decision whether or not to serve as a lead plaintiff. You may retain Milberg Weiss Bershad Hynes & Lerach LLP, or other counsel of your choice, to serve as your counsel in this action.

Milberg Weiss Bershad Hynes & Lerach LLP, a 170-lawyer firm with offices in New York City, San Diego, San Francisco, Los Angeles, Boca Raton, Seattle and Philadelphia, is active in major litigations pending in federal and state courts throughout the United States. Milberg Weiss has taken a leading role in many important actions on behalf of defrauded investors, consumers, and companies, as well as victims of World War II and other human rights violations, and has been responsible for more than $30 billion in aggregate recoveries. The Milberg Weiss Web site (www.milberg.com) has more information about the firm.

If you wish to discuss this action with us, or have any questions concerning this notice or your rights and interests with regard to the case, please contact the following attorneys:

Steven G. Schulman or Samuel H. Rudman One Pennsylvania Plaza, 49th fl., New York, NY, 10119-0165

CONTACT: Steven G. Schulman
800-320-5081

Samuel H. Rudman
800-320-5081



To: Suzanne Newsome who wrote (1809)3/21/2001 3:24:18 PM
From: Spytrdr  Read Replies (1) | Respond to of 2110
 
it's well below ipo price
spytrdr.com

___
<<I have read that the split-adjusted IPO price was $5.75.>>



To: Suzanne Newsome who wrote (1809)3/28/2001 3:40:57 AM
From: Dwight E. Karlsen  Respond to of 2110
 
The stock was just weak all day, for some reason. Since the volume was 25% higher than normal, and since the Nasdaq had the best day its had in probably ten sessions, I would attribute Tuesday's weakness mainly to Banc of America Securities cutting their estimate on Ariba's sales by 20% for the current q.

investor.cnet.com

Basically, it looks like everyone's deathly afraid that any day now, Ariba mgmt will pre-announce that they blew the quarter badly. Arba exec has previously made nervous comments to the effect that at the end of Feb., they still had to close 65% of the deals for the quarter in order to stay on target for prior sales estimates.

Who knows though. Look at how MANU was off 9% today, after exceeding both sales and earnings estimates. So you never can tell. Did you see this gem below that came onto the wire 25 minutes before the market closed? All you have to do is read through the second paragraph, and then you know why very few people actually invest in utility companies: They ain't too bright.

dailynews.yahoo.com

Utility Pepco Closes Its Online B2B Exchange

NEW YORK (Reuters) - Potomac Electric Power Co. (NYSE:POM - news) said on Tuesday it closed its business-to-business online exchange, citing a lack of demand for the service among its customers and partners.

The company, which provides electricity in the Washington D.C. and Delaware areas, set up the exchange, PepMarket.com, last September as a way of allowing customers to buy goods, such as office supplies and services, over the Internet.

--------

That's all that's worth reading in the article. All I want to know is, which hallucinagenic drug made the executives of Potomac Electric Power Co. think that people would want to buy their office supplies from their electric utility company? Next thing you know, we'll see hospitals closing down their B2B network because of a lack of demand for people wanting to order quote "goods, such as blue jeans and sunglasses, over the Internet" unquote.

I was not aware that Ariba's software solutions are limited in regards to direct procurement (i.e. materials for use in building/mfg whatever it is your company does). I think they probably can and do build such systems, but with the weath of ignorance out there regarding what exactly these companies do.

Here below is yesterday morning's latest customer acquisition by Ariba. I don't see any limitation on direct procurement:

biz.yahoo.com

Ariba Powers Private Marketplace for Fortune 100
Pharmaceutical Company To Complement Its Global
Strategic Sourcing Program

Process Cost Savings and Return on Investment Realized Immediately


MOUNTAIN VIEW, Calif., March 27 /PRNewswire/ -- Ariba, Inc. (Nasdaq: ARBA -
news), the global leader in B2B commerce and collaboration, recently developed a Private
Sourcing Exchange for Bristol-Myers Squibb (NYSE: BMY - news), a $20 billion
diversified, global health and personal care company. The Ariba-powered Private Sourcing
Exchange is a robust Internet-based tool for Bristol-Myers Squibb's RFQ-based purchases
for direct and indirect materials, business services, and capital assets. (note: RFQ = Request For Quote. Also, note the capital asset capability.)

One of Bristol-Myers Squibb's key Global Business Services organizations, Global Strategic
Sourcing was established as part of the Productivity for Growth Initiatives in 1996. Global
Strategic Sourcing was created to evaluate the way Bristol-Myers Squibb buys goods and
services and to determine how to add value to the way Bristol-Myers Squibb purchases as
an international company.

Over the past few years Bristol-Myers Squibb had dramatically improved their sourcing
process, but still lacked a tool which would allow them to harness the power of the Internet
to increase the efficiency and effectiveness of their traditional sourcing process. Given Ariba's
market leadership and the strong relationship already in place between the two companies, it
was natural for Bristol-Myers Squibb to turn to Ariba first.

Within six weeks Ariba Sourcing provided Bristol-Myers Squibb with a privately branded,
hosted sourcing platform. Ariba Sourcing not only provides sourcing software functionality,
but also an extensive set of services to ensure supply base liquidity and auction success.

Bristol-Myers Squibb has realized an average additional cost savings of 6-10 percent across
multiple product categories and process savings of over six weeks. Their sourcing
organizations have seen a savings of 4-6 weeks for the time to go through the entire
procurement process. This allows the department to focus on their two primary objectives:
to secure the best total value for goods and services Bristol-Myers Squibb buys as a
worldwide company, and to make the most informed sourcing, negotiating, and purchasing
decisions.

``Our six week implementation enabled a rapid return on investment for Bristol-Myers Squibb,'' said Mike Hills, vice president, North American operations for Ariba. ``We will continue to work closely with BMS to enable them to roll out the solution across their global organization, with the overall goal to reduce purchasing cycles and costs throughout the company.''

Bristol-Myers Squibb has also accelerated their implementation schedule and plans to implement the Ariba Sourcing Platform in Europe and Latin America in 2001.
======

Of course, BMY isn't nearly the same thing as a local electric power company trying to hawk paperclips and pens over the internet. And that is why it doesn't bother me to read about some so-called B2B exchange being shut down. There was definitely a gold-rush mentality throughout the economy, with lots of companies headed to "them thar hills" to pan for gold, when they should have known that the odds of hitting the mother lode where stacked against them. Some things truly don't change, regardless of history.

I knew that it was impossible to know where the bottom of a stock is except through hind-sight, and I have no regrets at being in at $10.75. Quite the contrary.